About this FactMed analysis covering adverse side effect reports of CALCITRAN B12 patients who developed OSTEOPENIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking CALCITRAN B12 reported OSTEOPENIA to the FDA. A total of 2 CALCITRAN B12 drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CALCITRAN B12 and OSTEOPENIA. In doing so, we compare CALCITRAN B12 with other drugs that cause OSTEOPENIA, to help you evaluate whether or not CALCITRAN B12 causes OSTEOPENIA. Likewise, this page shows the most highly-reported side effects of CALCITRAN B12, so you can see if OSTEOPENIA ranks among CALCITRAN B12's most well-known side effects.
Summary Statistics
Reports of CALCITRAN B12 causing OSTEOPENIA: 1
Reports of any side effect of CALCITRAN B12 : 2
Percentage of CALCITRAN B12 patients where OSTEOPENIA is a reported side effect: 50.0000%

FDA reports of any drug causing OSTEOPENIA : 6844
Average percentage for all medicated patients where OSTEOPENIA is reported as a complication: 0.0429%

Physician opinion on CALCITRAN B12 as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CALCITRAN B12:
Drugs with high FDA adverse event association with OSTEOPENIA:

FOSAMAX (4783 patients)
ZOMETA (2152 patients)
AREDIA (1754 patients)
ASPIRIN (1199 patients)
PREDNISONE (1006 patients)
ACCUTANE (847 patients)
NEXIUM (804 patients)
VIOXX (786 patients)
PRILOSEC (776 patients)
COUMADIN (661 patients)
DECADRON (640 patients)
AMBIEN (582 patients)
SYNTHROID (573 patients)
PREMARIN (558 patients)
CELEBREX (557 patients)
LIPITOR (553 patients)
LASIX (521 patients)
NEURONTIN (520 patients)
LEVAQUIN (482 patients)
PROTONIX (474 patients)
OXYCONTIN (457 patients)
DEXAMETHASONE (450 patients)
THALIDOMIDE (446 patients)
PERCOCET (438 patients)
VICODIN (422 patients)
FOLIC ACID (411 patients)
LISINOPRIL (410 patients)
ZOLOFT (407 patients)
ARIMIDEX (402 patients)
CALCIUM (393 patients)
ZOFRAN (392 patients)
ATIVAN (380 patients)
MULTI-VITAMINS (372 patients)
CLINDAMYCIN (370 patients)
VITAMIN D (370 patients)
ZOCOR (369 patients)
OXYCODONE HCL (361 patients)
XANAX (355 patients)
PREVACID (355 patients)
ACETAMINOPHEN (354 patients)
AMOXICILLIN (342 patients)
ATENOLOL (341 patients)
FEMARA (341 patients)
ACTONEL (339 patients)
TAMOXIFEN CITRATE (335 patients)
COMPAZINE (328 patients)
FUROSEMIDE (326 patients)
ALBUTEROL (325 patients)
FOSAMAX PLUS D (322 patients)
FLEXERIL (314 patients)
PAXIL (306 patients)
CALCIUM (UNSPECIFIED) (305 patients)
MORPHINE (303 patients)
TOPROL-XL (295 patients)
OMEPRAZOLE (294 patients)
PREDNISONE TAB (292 patients)
DILAUDID (289 patients)
LORTAB (287 patients)
NORVASC (280 patients)
CYTOXAN (279 patients)
METHOTREXATE (279 patients)
ZITHROMAX (278 patients)
PREMPRO (276 patients)
LORAZEPAM (276 patients)
PERIDEX (275 patients)
LOVENOX (274 patients)
REVLIMID (272 patients)
GABAPENTIN (269 patients)
LEXAPRO (267 patients)
IBUPROFEN (265 patients)
CALCIUM CARBONATE (263 patients)
ALLEGRA (261 patients)
COLACE (259 patients)
ARANESP (255 patients)
ZANTAC (254 patients)
CIPROFLOXACIN (253 patients)
PROZAC (251 patients)
SIMVASTATIN (246 patients)
PLAVIX (245 patients)
BONIVA (244 patients)
CELEXA (242 patients)
KEFLEX (240 patients)
FLAGYL (239 patients)
EVISTA (234 patients)
ASCORBIC ACID (231 patients)
REGLAN (231 patients)
CYMBALTA (228 patients)
AUGMENTIN '125' (223 patients)
RADIATION THERAPY (222 patients)
VITAMIN E (220 patients)
ZYRTEC (219 patients)
ALLOPURINOL (216 patients)
LYRICA (215 patients)
FLONASE (213 patients)
ADRIAMYCIN PFS (213 patients)
VITAMIN D (UNSPECIFIED) (212 patients)
PROCRIT /00909301/ (210 patients)
PEPCID (209 patients)
EPOGEN (209 patients)
PROVERA (208 patients)
FASLODEX (207 patients)
AROMASIN (206 patients)
XELODA (205 patients)
TAXOTERE (204 patients)
DOXYCYCLINE (204 patients)
VANCOMYCIN (201 patients)
ADVAIR DISKUS 100/50 (198 patients)
NITROGLYCERIN (197 patients)
MS CONTIN (197 patients)
DIFLUCAN (197 patients)
WARFARIN SODIUM (196 patients)
CEPHALEXIN (195 patients)
VELCADE (194 patients)
ACYCLOVIR (193 patients)
DIOVAN (193 patients)
RANITIDINE (189 patients)
SEROQUEL (188 patients)
TAXOL (178 patients)
LOPRESSOR (178 patients)
DIGOXIN (178 patients)
DURAGESIC-100 (177 patients)
HYDROCORTISONE (176 patients)
BACTRIM (175 patients)
CIPRO (174 patients)
VINCRISTINE (174 patients)
SINGULAIR (174 patients)
ESTRADERM (170 patients)
NYSTATIN (170 patients)
PROMETHAZINE (167 patients)
AVELOX (166 patients)
FISH OIL (166 patients)
POTASSIUM (165 patients)
FENTANYL (163 patients)
KLONOPIN (162 patients)
DEPO-PROVERA (162 patients)
COZAAR (160 patients)
ROCEPHIN (160 patients)
MULTIVITAMIN ^LAPPE^ (158 patients)
IRON (157 patients)
EFFEXOR (155 patients)
VALIUM (155 patients)
TYLENOL-500 (152 patients)
MEGACE (152 patients)
TYLENOL (150 patients)
FLUCONAZOLE (148 patients)
ALKERAN (148 patients)
REMICADE (148 patients)
PRAVACHOL (147 patients)
TRAZODONE HCL (147 patients)
DARVOCET-N 50 (146 patients)
OXYCODONE (146 patients)
ALPRAZOLAM (145 patients)
AVONEX (144 patients)
METRONIDAZOLE (140 patients)
ENBREL (139 patients)
FERROUS SULFATE TAB (139 patients)
ACIPHEX (137 patients)
NEUPOGEN (135 patients)
VITAMIN B6 (134 patients)
MIACALCIN (134 patients)
GLUCOSAMINE (130 patients)
ELAVIL (130 patients)
FLOMAX (130 patients)
HERCEPTIN (129 patients)
CLARITIN (129 patients)
MIRALAX (129 patients)
DIAZEPAM (128 patients)
AMITRIPTYLINE HCL (127 patients)
MOBIC (127 patients)
LOMOTIL (127 patients)
CARDIZEM (127 patients)
DARVOCET-N 100 (127 patients)
BEXTRA (122 patients)
VALTREX (122 patients)
FORTEO (122 patients)
HYDROCODONE (120 patients)
MORPHINE SULFATE (120 patients)
ZETIA (120 patients)
AVASTIN (118 patients)
[THERAPY UNSPECIFIED] (117 patients)
PENICILLIN VK (117 patients)
NAPROXEN (117 patients)
KLOR-CON (115 patients)
BENADRYL ^ACHE^ (113 patients)
BENADRYL (113 patients)
TRAMADOL HCL (113 patients)
LUPRON (112 patients)
CARBOPLATIN (112 patients)
LEVOXYL (111 patients)
WELLBUTRIN (110 patients)
ESTRACE (110 patients)
COREG (109 patients)
SENOKOT (109 patients)
ULTRAM (108 patients)
DEMEROL (107 patients)
SOMA (107 patients)
SPIRONOLACTONE (107 patients)
ZOLPIDEM (106 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for CALCITRAN B12

Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about OSTEOPENIA and CALCITRAN B12, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking CALCITRAN B12, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in CALCITRAN B12. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CALCITRAN B12 experts. If you are a healthcare provider experienced in prescribing CALCITRAN B12, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use